Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 28, 2005; 11(12): 1809-1812
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1809
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1809
Group | Dosage (mg/kg) | GSH (µg/mg prot) | SOD (U/mg prot) | MDA (nmol/mg prot) | General protein (mg/mL) |
Normal control | – | 27.75±0.86b | 26.10±0.81b | 0.55±0.025b | 21.22±0.39 |
Model control | – | 14.93±0.45 | 19.05±0.73 | 1.06±0.040 | 21.13±0.35 |
HGF | 3 | 19.02±0.42b | 21.82±0.82b | 0.89±0.038b | 21.28±0.49 |
S-8300 | 0.3 | 17.40±0.10b | 21.19±0.69b | 0.91±0.035b | 21.3±0.29 |
1 | 20.01±0.74b | 23.39±0.42b | 0.81±0.026b | 21.11±0.44 | |
3 | 24.17±0.91b | 24.51±1.01b | 0.64±0.027b | 21.3±0.43 |
- Citation: Huang FJ, Lv ZB, Li Q, Wei LJ, Zhang L, Wu WT. Study on hepatoprotective effect of peptide S-8300 from shark liver. World J Gastroenterol 2005; 11(12): 1809-1812
- URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1809.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1809